000 | 01905 a2200553 4500 | ||
---|---|---|---|
005 | 20250513234549.0 | ||
264 | 0 | _c20010628 | |
008 | 200106s 0 0 eng d | ||
022 | _a0196-6553 | ||
024 | 7 |
_a10.1067/mic.2001.110367 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSorvillo, F | |
245 | 0 | 0 |
_aIncidence and determinants of Pseudomonas aeruginosa infection among persons with HIV: association with hospital exposure. _h[electronic resource] |
260 |
_bAmerican journal of infection control _cApr 2001 |
||
300 |
_a79-84 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xepidemiology |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
650 | 0 | 4 |
_aAzithromycin _xtherapeutic use |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 |
_aCross Infection _xepidemiology |
650 | 0 | 4 |
_aDapsone _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHealth Behavior |
650 | 0 | 4 |
_aHospitalization _xstatistics & numerical data |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 | _aInfection Control |
650 | 0 | 4 |
_aLength of Stay _xstatistics & numerical data |
650 | 0 | 4 |
_aLos Angeles _xepidemiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 |
_aPseudomonas Infections _xepidemiology |
650 | 0 | 4 | _aPseudomonas aeruginosa |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aRisk-Taking |
650 | 0 | 4 |
_aTrimethoprim, Sulfamethoxazole Drug Combination _xadverse effects |
700 | 1 | _aBeall, G | |
700 | 1 | _aTurner, P A | |
700 | 1 | _aBeer, V L | |
700 | 1 | _aKovacs, A A | |
700 | 1 | _aKerndt, P R | |
773 | 0 |
_tAmerican journal of infection control _gvol. 29 _gno. 2 _gp. 79-84 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1067/mic.2001.110367 _zAvailable from publisher's website |
999 |
_c11223201 _d11223201 |